• CLCC1 and Herpesvirus Nuclear Egress

  2026-08-16

  A 2024 bioRxiv preprint identifies CLCC1 as an essential host factor for the membrane-fusion step of herpesvirus nuclear egress. The study connects CLCC1 loss with perinuclear capsid accumulation, reduced viral production, and defective nuclear pore complex insertion, suggesting a shared membrane-remodeling mechanism in infection and uninfected cells.

• YM 58483 (BTP2) SOCE Blocker Guide

  2026-08-15

  This scenario-driven guide explains how YM 58483 (BTP2), a store-operated Ca2+ entry (SOCE) blocker, can clarify calcium-dependent results in T-cell, viability, cytotoxicity, and fibrosis assays. It provides practical interpretation and handling guidance for SKU B7542, with links to product information and primary literature.

• Isradipine (Dynacirc): Calcium Channel Workflows

  2026-08-14

  Isradipine (Dynacirc) provides a practical L-type calcium channel control for neuronal calcium-imaging, electrophysiology, and vascular smooth muscle experiments. This guide connects reproducible compound handling with a key pharmacology lesson: channel blockers must be interpreted within the selectivity and assay context.

• Balsalazide Disodium in Colitis Research

  2026-08-14

  Balsalazide disodium is a colon-targeted 5-aminosalicylic acid prodrug used in inflammation research and inflammatory bowel disease models. Its azoreductase-dependent activation, radiolabeling benchmarks, aqueous solubility, and preclinical limitations support controlled immunology assay design rather than direct extrapolation from animal or clinical dosing.

• ML133 HCl: Kir2.1 Workflow for Vascular Research

  2026-08-13

  ML133 HCl is a selective potassium channel inhibitor for connecting Kir2.1 activity with pulmonary artery smooth muscle cell behavior, vascular remodeling, and signaling. This practical guide covers assay setup, pH-aware dosing, migration and proliferation workflows, comparative controls, and troubleshooting.

• Polygodial for TRPA1 Channel Activation Studies

  2026-08-13

  Polygodial enables time-resolved TRPA1 activation studies that connect acute calcium entry with downstream NFAT and epithelial cytokine responses. This workflow combines live-cell ion-channel measurements, orthogonal pathway controls, and practical DMSO handling for sensory biology and neurophysiology research.

• Verapamil Beyond Cardiology: Hypoxia and Inflammation

  2026-08-12

  Verapamil is best known as a calcium channel blocker, yet recent urothelial-cell research positions it as a useful pharmacological probe for hypoxia-driven ROS/TXNIP/NLRP3 signaling. This article translates that finding into a rigorous, limitation-aware workflow for translational researchers.

• Nifedipine (BAY-a-1040) Assay Workflows

  2026-08-12

  A scenario-based guide to using Nifedipine (BAY-a-1040), SKU B1988, in calcium-dependent viability, proliferation, iron-transport, and comparative cell assays. It emphasizes solvent control, concentration selection, orthogonal readouts, storage, and evidence-based interpretation.

• UK-5099 for Mitochondrial Metabolism Research

  2026-08-11

  UK-5099, also called PF-1005023, enables controlled interrogation of mitochondrial pyruvate entry in whole blood, insulinoma cells, and isolated mitochondria. This guide translates a standardized immunometabolism workflow into practical dosing, controls, readouts, and troubleshooting strategies.

• ML133 HCl: Selective Kir2.1 Potassium Channel Inhibitor

  2026-08-11

  ML133 HCl enables selective interrogation of Kir2.1-dependent potassium ion transport in pulmonary vascular cell models. This workflow-focused guide connects inhibitor handling, PASMC proliferation and migration assays, pathway readouts, and troubleshooting to findings from a pulmonary hypertension study.

• Carvedilol Phosphate in Cell Assay Workflows

  2026-08-10

  This scenario-driven guide shows how Carvedilol Phosphate, SKU C6404, can support controlled beta-adrenergic signaling experiments while reducing avoidable formulation and interpretation errors. It connects solubility, purity, storage, assay controls, and hepatic ischemia–reperfusion research to practical laboratory decisions.

• Nav1.5 Ser571 Phosphorylation in Cardiac Aging

  2026-08-09

  The 2024 reference study identifies Nav1.5 phosphorylation at Ser571 as a mechanistic link between increased late sodium current, delayed ventricular repolarization, and impaired diastolic function during cardiac aging. By combining phosphomimetic and phosphoablated mouse models with electrocardiography, ventricular myocyte electrophysiology, calcium imaging, and contractility measurements, the work shows that late sodium current is not only associated with aging myopathy but helps organize its electrical and mechanical phenotype.

• Spermine: From Ion Channels to Fusion Assays

  2026-08-08

  Spermine is an endogenous polyamine best known for inward rectifier potassium channel modulation, but its value extends to better-controlled cell biology experiments. This article connects its biophysical mechanism with the CLCC1 nuclear egress study while clearly separating established evidence from testable assay hypotheses.

• ML133 HCl: From Channel Block to Causal Assays

  2026-08-07

  ML133 HCl is a selective potassium channel inhibitor for dissecting Kir2.1-dependent signaling in pulmonary vascular cells. This guide goes beyond product description to show how selectivity, pH, pathway controls, and orthogonal readouts improve cardiovascular ion channel research.

• 2-(4,5,6,7-tetrabromo...)acetic Acid: Small Molecule Inhibit

  2026-08-07

  Leverage the CK2 and ERK8 inhibitor (SKU: B7464) for precise modulation of kinase-driven signaling and protein phase separation in advanced biochemical research. Discover protocol optimizations, troubleshooting strategies, and cross-domain applications that set this small molecule inhibitor apart.

11572 records 1/772 page Next 12345 下5页 Last page